The open, multicenters, double-arms, randomized, parallel controlled clinical trial of lobaplatin or gemcitabine combined with docetaxel as second-line therapy for advanced osteosarcoma-the effectiveness and safety analysis.

Yuanjue Sun,Yang Yao,Zhengdong Cai,Xiuchun Yu,Sujia Wu,Zhaoming Ye,Yingqi Hua,Shui’er Zheng,Guojing Chen,Yong‐cheng Hu,Yong Zhou,Zhen Wang

The open, multicenters, double-arms, randomized, parallel controlled clinical trial of lobaplatin or gemcitabine combined with docetaxel as second-line therapy for advanced osteosarcoma-the effectiveness and safety analysis.

2017

Yuanjue Sun
Yang Yao
Zhengdong Cai
Xiuchun Yu
Sujia Wu
Zhaoming Ye
Yingqi Hua
Shui’er Zheng
Guojing Chen
Yong‐cheng Hu
Yong Zhou
Zhen Wang

e22506Background: to study the progression free survival (PFS), objective response rate (ORR), overall survival (OS) and safety of lobaplatin or gemcitabine combined with docetaxel as second-line t...

Keywords:

Clinical trial
Lobaplatin
Oncology
Second-line therapy
Physical therapy
Osteosarcoma
Gemcitabine
Medicine
Internal medicine
Docetaxel
overall survival
Progression-free survival
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations